SCHEMBL27906348

SCHEMBL27906348

CC(=O)Oc1cc(-c2ccccc2)n[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.55
TP53 P04637 1/20 0.54
CHEK1 O14757 1/20 0.53
RET P07949 1/20 0.53
PDGFRB P09619 1/20 0.53
PIM1 P11309 1/20 0.53
PDGFRA P16234 1/20 0.53
GSK3B P49841 1/20 0.53
RPS6KA3 P51812 1/20 0.53
LIMK1 P53667 1/20 0.53
CDK5 Q00535 1/20 0.53
TYRO3 Q06418 1/20 0.53
MAPK14 Q16539 1/20 0.53
LRRK2 Q5S007 1/20 0.53
AURKB Q96GD4 1/20 0.53
CLK4 Q9HAZ1 1/20 0.53
DYRK1B Q9Y463 1/20 0.53
ADORA3 P0DMS8 1/20 0.52
ADORA2A P29274 1/20 0.52
ADORA2B P29275 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417260 0.87 TP53 (0.57) GAATP53CHEK1RETPDGFRB
SCHEMBL27909175 0.84 ALPL (0.55) RETRAB9AALPLCA9ALOX15
SCHEMBL28015306 0.81 BACE1 (0.49) TP53ADORA3ACRRAB9APOLB
SCHEMBL10673565 0.81 GAA (0.49) GAATP53CHEK1RETPDGFRB
SCHEMBL27894413 0.79 ALPL (0.57) TP53RAB9AALPLALOX15MEN1
SCHEMBL7644462 0.78 L3MBTL1 (0.58) GAATP53CHEK1RETPDGFRB
SCHEMBL27865531 0.75 CYP3A4 (0.40) GAATP53BACE1MAPTSMN1; SMN2
SCHEMBL17280250 0.75 RAB9A (0.53) GAATP53CHEK1RETPDGFRB
SCHEMBL10242682 0.75 TP53 (0.74) GAATP53CHEK1RETPDGFRB
SCHEMBL2374336 0.73 L3MBTL1 (0.53) GAATP53CHEK1RETPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102906093-B NK-3 receptor selective antagonists compound, pharmaceutical composition and the using method in the receptor-mediated disease of NK-3 EUROSCREEN S.A. (BE) 2016-01-13 CN disclosed
CN-102906093-A Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders EUROSCREEN SA 2013-01-30 CN disclosed